WRK
60
-3
CNP
65
-3
IPG
42
-2
PBI
30
7
F
42
-4
FRT
38
-3
SWKS
57
-8
AMGN
47
-13
UNP
50
4
GIS
54
2
WY
27
-7
EMC
77
-8
CVX
23
-2
MCD
46
4
ADM
36
2
VZ
25
-2
ALL
45
-3
XYL
43
-4
AA
38
3
GILD
50
13
WRK
60
-3
CNP
65
-3
IPG
42
-2
PBI
30
7
F
42
-4
FRT
38
-3
SWKS
57
-8
AMGN
47
-13
UNP
50
4
GIS
54
2
WY
27
-7
EMC
77
-8
CVX
23
-2
MCD
46
4
ADM
36
2
VZ
25
-2
ALL
45
-3
XYL
43
-4
AA
38
3
GILD
50
13
Financhill
Back

Celsius Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

CELH
Celsius Holdings

Last Price:
62.49
Seasonality Move:
18.32%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
46
Celsius Holdings (CELH) is a Sell

Is Celsius Holdings a Buy, Sell or Hold?

  • The current Celsius Holdings [CELH] share price is $62.48. The Score for CELH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CELH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CELH Stock Price Chart

What is Celsius Holdings's stock price today?

  • The Celsius Holdings share price today is $62.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CELH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CELH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.78 Sell
Relative Strength Index (14 RSI): 35.2 Sell
Chaikin Money Flow: 3884309 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.54 - 89.2) Sell
Bollinger Bands (100): (63.46 - 88.28) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

CELH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.95 Buy
20-day SMA: 71.91 Sell
50-day SMA: 76.43 Sell
200-day SMA: 65.73 Sell
8-day EMA: 63.51 Sell
20-day EMA: 69.62 Sell
50-day EMA: 74.67 Sell
200-day EMA: 66.8 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Celsius Holdings Earnings Growth & CELH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.06 per share, an increase this year of $0.33 per share, and an increase next year of $0.38 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Celsius Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):